These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 34616003)
1. Comment on: Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy. Elnahry AG; Yussuf WA Eye (Lond); 2022 Aug; 36(8):1705. PubMed ID: 34616003 [No Abstract] [Full Text] [Related]
2. Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy. Chatziralli I; Touhami S; Cicinelli MV; Agapitou C; Dimitriou E; Theodossiadis G; Theodossiadis P Eye (Lond); 2022 Apr; 36(4):692-703. PubMed ID: 34408316 [TBL] [Abstract][Full Text] [Related]
3. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381 [TBL] [Abstract][Full Text] [Related]
4. Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat. Yamada H; Yamada E; Higuchi A; Matsumura M Diabetologia; 2005 Aug; 48(8):1663-8. PubMed ID: 15977012 [TBL] [Abstract][Full Text] [Related]
5. Xanthosis (vel discoloratio flava) fundi diabetica, and the appearance of sharply outlined retinal vessels; hitherto unnoticed characteristic features in diabetic retinopathy. FEIGENBAUM A Ophthalmologica; 1949; 118(4-5):632-6. PubMed ID: 15409061 [No Abstract] [Full Text] [Related]
6. [Current possibilities in visualization of retinal periphery in diabetic retinopathy]. Petrachkov DV; Budzinskaya MV; Baryshev KV Vestn Oftalmol; 2020; 136(4. Vyp. 2):272-278. PubMed ID: 32880150 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes. Hu B; Zhang Y; Zeng Q; Han Q; Zhang L; Liu M; Li X Int J Mol Sci; 2014 Jan; 15(1):1606-24. PubMed ID: 24451141 [TBL] [Abstract][Full Text] [Related]
9. Retinal Physiology and Circulation: Effect of Diabetes. Wright WS; Eshaq RS; Lee M; Kaur G; Harris NR Compr Physiol; 2020 Jul; 10(3):933-974. PubMed ID: 32941691 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy. Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114 [TBL] [Abstract][Full Text] [Related]
11. Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats. Zhu Y; Zhang XL; Zhu BF; Ding YN Mol Biol Rep; 2012 Apr; 39(4):3727-35. PubMed ID: 21952821 [TBL] [Abstract][Full Text] [Related]
12. [THE RELATIONSHIP BETWEEN TOTAL BLOOD CHOLESTEROL AND PERIPHERAL BLOOD PRESSURE AND CENTRAL ARTERIAL PRESSURE OF THE RETINA IN DIABETICS. (2) ON DIABETIC RETINOPATHY]. KOJIMA K; NIIMI K; WATANABE I; SHIOI M Rinsho Ganka; 1964 Apr; 18():488-91. PubMed ID: 14165717 [No Abstract] [Full Text] [Related]
13. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505 [TBL] [Abstract][Full Text] [Related]
14. Role of endothelin in diabetic retinopathy. Lam HC; Lee JK; Lu CC; Chu CH; Chuang MJ; Wang MC Curr Vasc Pharmacol; 2003 Oct; 1(3):243-50. PubMed ID: 15320471 [TBL] [Abstract][Full Text] [Related]
15. Peripheral retinal vessel whitening in patients with diabetes mellitus. Kalaw FGP; Sharma P; Kako RN; Walker E; Borooah S Sci Rep; 2023 May; 13(1):7981. PubMed ID: 37198200 [TBL] [Abstract][Full Text] [Related]
16. New developments in angiography for the diagnosis and management of diabetic retinopathy. Mustafi D; Saraf SS; Shang Q; Olmos de Koo LC Diabetes Res Clin Pract; 2020 Sep; 167():108361. PubMed ID: 32745697 [TBL] [Abstract][Full Text] [Related]
17. VEGF localisation in diabetic retinopathy. Boulton M; Foreman D; Williams G; McLeod D Br J Ophthalmol; 1998 May; 82(5):561-8. PubMed ID: 9713066 [TBL] [Abstract][Full Text] [Related]
18. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina. Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026 [TBL] [Abstract][Full Text] [Related]
19. Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects. Sun W; Gerhardinger C; Dagher Z; Hoehn T; Lorenzi M Diabetes; 2005 Dec; 54(12):3418-26. PubMed ID: 16306357 [TBL] [Abstract][Full Text] [Related]
20. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]